B Group, Inc. Zai Lab LTD Transaction History
B Group, Inc.
- $164 Billion
- Q4 2024
A detailed history of B Group, Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, B Group, Inc. holds 400,000 shares of ZLAB stock, worth $15.3 Million. This represents 6.4% of its overall portfolio holdings.
Number of Shares
400,000Holding current value
$15.3 Million% of portfolio
6.4%Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$255 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$252 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$247 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$121 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$96.2 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.75B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...